海爾生物(688139.SH):奇君投資累計減持5%股份 持股比例減至15.25%
格隆匯9月22日丨海爾生物(688139.SH)公佈,公司於2021年9月22日收到公司股東奇君投資發來的《青島海爾生物醫療股份有限公司簡式權益變動報吿書》,2020年2月28日-2021年9月22日,奇君投資累計減持1585.72萬股,佔總股本比例5.00%。
本次權益變動後,寧波梅山保税港區奇君股權投資合夥企業(有限合夥)(“奇君投資”)持有公司股份數量從64,207,317股減少至48,350,071股,持有股份佔公司總股本比例從20.25%減少至15.25%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.